Kinetics of neurodegeneration based on a risk-related biomarker in animal model of glaucoma

Molecular Neurodegeneration

Volumn 8, Issue 1, 2013, Pages

  Hayashi, Takuya ^a,b,c,d,e   Shimazawa, Masamitsu ^a,f   Watabe, Hiroshi ^a,b,g   Ose, Takayuki ^a,b   Inokuchi, Yuta ^f   Ito, Yasushi ^f   Yamanaka, Hajime ^a   Urayama, Shin Ichi ^c   Watanabe, Yasuyoshi ^a,e   Hara, Hideaki ^a,f   Onoe, Hirotaka ^a,e  

^a RIKEN   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^g OSAKA UNIVERSITY   (Japan)

Author keywords

Biomarker; Diffusion tensor; Glaucoma; Kinetic model; Neurodegenerative mechanisms

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; GLAUCOMA; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; KINETICS; MACACA FASCICULARIS; MALE; NERVE DEGENERATION; NERVE FIBER; NONHUMAN; OPTIC NERVE; PREDICTIVE VALUE; PROBABILITY; RISK ASSESSMENT; VISUAL SYSTEM; WHITE MATTER;

ANIMALS; DIFFUSION TENSOR IMAGING; DISEASE MODELS, ANIMAL; GLAUCOMA; INTRAOCULAR PRESSURE; KINETICS; NERVE DEGENERATION; RISK FACTORS;

ANIMALIA;

EID: 84872290701     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-8-4     Document Type: Article

References (62)

1. Looking backward to move forward: early detection of neurodegenerative disorders. DeKosky ST, Marek K, Science 2003 302 830 834 10.1126/science.1090349 14593169 (Pubitemid 37339617)
2. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ, Lancet Neurol 2010 9 119 128 10.1016/S1474-4422(09) 70299-6 20083042
3. High Degree of Heterogeneity in Alzheimer's Disease Progression Patterns. Komarova NL, Thalhauser CJ, PLoS Comput Biol 2011 7 1002251 10.1371/journal.pcbi.1002251 22072952
4. CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM, J Neurosci 2010 30 2088 2101 10.1523/JNEUROSCI.3785-09.2010 20147537
5. CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease. Perneczky R, Tsolakidou A, Arnold A, Diehl-Schmid J, Grimmer T, Förstl H, Kurz A, Alexopoulos P, Neurology 2011 77 35 38 10.1212/WNL.0b013e318221ad47 21700579
6. MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Dickerson BC, Wolk DA, Neurology 2012 78 84 90 10.1212/WNL.0b013e31823efc6c 22189451
7. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Shaw LM, Korecka M, Clark CM, Lee VM-Y, Trojanowski JQ, Nat Rev Drug Discov 2007 6 295 303 10.1038/nrd2176 17347655 (Pubitemid 46505880)
8. Biomarkers for parkinson's disease. Sherer TB, Sci Transl Med 2011 3 79ps14 10.1126/scitranslmed.3002488 21508309
9. Aging of the brain, entropy, and Alzheimer disease. Drachman DA, Neurology 2006 67 1340 1352 10.1212/01.wnl.0000240127.89601.83 17060558 (Pubitemid 44632055)
10. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Dunnett SB, Bjorklund A, Nature 1999 399 32 A39 10392578
11. A one-hit model of cell death in inherited neuronal degenerations. Clarke G, Collins RA, Leavitt BR, Andrews DF, Hayden MR, Lumsden CJ, McInnes RR, Nature 2000 406 195 199 10.1038/35018098 10910361 (Pubitemid 30469003)
12. On the probabilistic nature of excitotoxic neuronal death in hippocampal neurons. Dubinsky JM, Kristal BS, Elizondo-Fournier M, Neuropharmacology 1995 34 701 711 10.1016/0028-3908(95)00041-4 8532137
13. Nucleation of protein aggregation kinetics as a basis for genotype-phenotype correlations in polyglutamine diseases. Sugaya K, Matsubara S, Mol Neurodegener 2009 4 29 10.1186/1750-1326-4-29 19602294
14. The laminar organization and cell content of the lateral geniculate body in the monkey. Clark LG, J Anat Lond 1941 75 419 433
15. Degeneration of Spared Axons Following Partial White Matter Lesion: Implications for Optic Nerve Neuropathies. Yoles E, Schwartz M, Exp Neurol 1998 153 1 7 10.1006/exnr.1998.6811 9743562 (Pubitemid 28452292)
16. Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration. Yucel Y, Gupta N, Prog Brain Res 2008 173 465 478 18929128
17. Primary open-angle glaucoma. Kwon YH, Fingert JH, Kuehn MH, Alward WL, N Engl J Med 2009 360 1113 1124 10.1056/NEJMra0804630 19279343
18. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Leskea MC, Heijl A, Hyman L, Bengtsson B, Komaroff E, Curr Opin Ophthalmol 2004 15 102 106 10.1097/00055735-200404000-00008 15021220 (Pubitemid 38457128)
19. Changes in visual fields and lateral geniculate nucleus in monkey laser-induced high intraocular pressure model. Sasaoka M, Nakamura K, Shimazawa M, Ito Y, Araie M, Hara H, Exp Eye Res 2008 86 770 782 10.1016/j.exer.2008.02. 004 18378230
20. Morphometric evaluation of changes with time in optic disc structure and thickness of retinal nerve fibre layer in chronic ocular hypertensive monkeys. Shimazawa M, Tomita G, Taniguchi T, Sasaoka M, Hara H, Kitazawa Y, Araie M, Exp Eye Res 2006 82 427 440 10.1016/j.exer.2005.08.001 16388801 (Pubitemid 43138956)
21. Glaucoma as a neurodegenerative disease. Gupta N, Yücel YH, Curr Opin Ophthalmol 2007 18 110 114 10.1097/ICU.0b013e3280895aea 17301611
22. Neuroprotection in glaucoma: recent and future directions. Danesh-Meyer HV, Curr Opin Ophthalmol 2011 22 78 86 10.1097/ICU.0b013e32834372ec 21252670
23. DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Douaud G, Jbabdi S, Behrens TEJ, Menke RA, Gass A, Monsch AU, Rao A, Whitcher B, Kindlmann G, Matthews PM, Smith S, Neuroimage 2011 55 880 890 10.1016/j.neuroimage.2010.12.008 21182970
24. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. Rose SE, Chen F, Chalk JB, Zelaya FO, Strugnell WE, Benson M, Semple J, Doddrell DM, J Neurol Neurosurg Psychiatr 2000 69 528 530 10.1136/jnnp.69.4.528 10990518
25. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. Yoshikawa K, Nakata Y, Yamada K, Nakagawa M, J Neurol Neurosurg Psychiatr 2004 75 481 484 10.1136/jnnp.2003.021873 14966170 (Pubitemid 38338784)
26. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Péran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, Celsis P, Rascol O, Démonet J-F, Stefani A, Pierantozzi M, Pontieri FE, Caltagirone C, Spalletta G, Sabatini U, Brain 2010 133 3423 3433 10.1093/brain/awq212 20736190
27. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Ellis CM, Simmons A, Jones DK, Bland J, Dawson JM, Horsfield MA, Williams SC, Leigh PN, Neurology 1999 53 1051 1058 10.1212/WNL.53.5.1051 10496265 (Pubitemid 29442122)
28. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Sach M, Winkler G, Glauche V, Liepert J, Heimbach B, Koch MA, Büchel C, Weiller C, Brain 2004 127 340 350 10.1093/brain/awh041 14607785 (Pubitemid 38160319)
29. Optic nerve and optic radiation neurodegeneration in patients with glaucoma: in vivo analysis with 3-T diffusion-tensor MR imaging. Garaci FG, Bolacchi F, Cerulli A, Melis M, Spanò A, Cedrone C, Floris R, Simonetti G, Nucci C, Radiology 2009 252 496 501 10.1148/radiol.2522081240 19435941
30. MR diffusion tensor spectroscopy and imaging. Basser PJ, Mattiello J, LeBihan D, Biophys J 1994 66 259 267 10.1016/S0006-3495(94)80775-1 8130344 (Pubitemid 24016507)
31. Diffusion MRI. Beaulieu C, From Quantitative Measurement to In Vivo Neuroanatomy Elsevier, London, Johansen-Berg H, Behrens T, 2009
32. Laser energy levels for trabecular meshwork damage in the primate eye. Quigley HA, Hohman RM, Invest Ophthalmol Vis Sci 1983 24 1305 1307 6885314 (Pubitemid 13006627)
33. Scale-free neurodegeneration: cellular heterogeneity and the stretched exponential kinetics of cell death. Clarke G, Lumsden CJ, J Theor Biol 2005 233 515 525 10.1016/j.jtbi.2004.10.028 15748912 (Pubitemid 40320597)
34. Statistical model for stretched exponential relaxation in macroscopic systems. Huber DL, Phys Rev B 1985 31 6070 6071 10.1103/PhysRevB.31.6070
35. Single retinal ganglion cells projecting bilaterally to the lateral geniculate nuclei or superior colliculi by way of axon collaterals in the cat. Kondo Y, Takada M, Tokuno H, Mizuno N, J Comp Neurol 1994 346 119 126 10.1002/cne.903460108 7962706 (Pubitemid 2118683)
36. Immunoreactive phosphorylated epitopes on neurofilaments in neuronal perikarya may be obscured by tissue preprocessing. Poltorak M, Freed WJ, Brain Res 1989 480 349 354 10.1016/0006-8993(89)90206-0 2469517 (Pubitemid 19050235)
37. Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Gusella JF, MacDonald ME, Nat Rev Neurosci 2000 1 109 115 11252773
38. Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins. Murphy RM, Biochim Biophys Acta 2007 1768 1923 1934 10.1016/j.bbamem.2006.12.014 17292851 (Pubitemid 47125847)
39. Probing the biology of Alzheimer's disease in mice. Ashe KH, Zahs KR, Neuron 2010 66 631 645 10.1016/j.neuron.2010.04.031 20547123
40. Protein homeostasis and aging in neurodegeneration. Douglas PM, Dillin A, J Cell Biol 2010 190 719 729 10.1083/jcb.201005144 20819932
41. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Craft S, Arch Neurol 2009 66 300 305 10.1001/archneurol.2009.27 19273747
42. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Prinz M, Priller J, Sisodia SS, Ransohoff RM, Nat Neurosci 2011 14 1227 1235 21952260
43. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC, Ann Neurol 2010 67 317 324 20373343
44. A framework for voxel-based morphometric analysis of the optic radiation using diffusion tensor imaging in glaucoma. El-Rafei A, Engelhorn T, Wärntges S, Dörfler A, Hornegger J, Michelson G, Magn Reson Imaging 2011 29 1076 1087 10.1016/j.mri.2011.02.034 21802876
45. Non-mono-exponential attenuation of water and N-acetyl aspartate signals due to diffusion in brain tissue. Assaf Y, Cohen Y, J Magn Reson 1998 131 69 85 10.1006/jmre.1997.1313 9533908 (Pubitemid 128450537)
46. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS, Brain 2010 133 3336 3348 10.1093/brain/awq277 20935035
47. Prion-like transmission of protein aggregates in neurodegenerative diseases. Brundin P, Melki R, Kopito R, Nat Rev Mol Cell Biol 2010 11 301 307 10.1038/nrm2873 20308987
48. Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices. Pate BD, Kawamata T, Yamada T, McGeer EG, Hewitt KA, Snow BJ, Ruth TJ, Calne DB, Ann Neurol 1993 34 331 338 10.1002/ana.410340306 8363350 (Pubitemid 23259601)
49. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, Eggert K, Oertel W, Banati RB, Brooks DJ, Neurobiol Dis 2006 21 404 412 10.1016/j.nbd.2005.08.002 16182554 (Pubitemid 43099863)
50. An alteration in the lateral geniculate nucleus of experimental glaucoma monkeys: In vivo positron emission tomography imaging of glial activation. Shimazawa M, Ito Y, Inokuchi Y, Yamanaka H, Nakanishi T, Hayashi T, Ji B, Higuchi M, Suhara T, Imamura K, Araie M, Watanabe Y, Onoe H, Hara H, PLoS One 2012 7 30526 10.1371/journal.pone.0030526 22299044
51. Modeling clinical features of neurodegeneration. Obeso JA, Nat Med 2010 16 1372 21135843
52. Theoretical estimation of maximum human lifespan. Weon BM, Je JH, Biogerontology 2009 10 65 71 10.1007/s10522-008-9156-4 18560989
53. A statistical distribution function of wide applicability. Weibull W, J Appl Mech 1951 18 293 297
54. Morphological changes in the visual pathway induced by experimental glaucoma in Japanese monkeys. Ito Y, Shimazawa M, Chen Y-N, Tsuruma K, Yamashima T, Araie M, Hara H, Exp Eye Res 2009 89 246 255 10.1016/j.exer.2009.03.013 19341728
55. Reduction of eddy-current-induced distortion in diffusion MRI using a twice-refocused spin echo. Reese TG, Heid O, Weisskoff RM, Wedeen VJ, Magn Reson Med 2003 49 177 182 10.1002/mrm.10308 12509835 (Pubitemid 36042349)
56. Advances in functional and structural MR image analysis and implementation as FSL. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM, Neuroimage 2004 23 Suppl 1 208 S219 15501092
57. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE, Neuroimage 2006 31 1487 1505 10.1016/j.neuroimage.2006.02.024 16624579
58. Fast robust automated brain extraction. Smith SM, Hum Brain Mapp 2002 17 143 155 10.1002/hbm.10062 12391568 (Pubitemid 35253488)
59. Nonrigid registration using free-form deformations: application to breast MR images. Rueckert D, Sonoda LI, Hayes C, Hill DL, Leach MO, Hawkes DJ, IEEE Trans Med Imaging 1999 18 712 721 10.1109/42.796284 10534053 (Pubitemid 32262025)
60. Bowden DM, Martin MF, Primate Brain Maps: Structure of the Macaque Brain: A Laboratory Guide with Original Brain Sections, Printed Atlas and Electronic Templates for Data and Schematics Elsevier Science, Amsterdam 1 2000
61. Regression Models and Life-Tables. Cox DR, J Statist Assoc Series B (Methodological) 1972 34 187 220
62. Time-dependent covariates in the Cox proportional-hazards regression model. Fisher LD, Lin DY, Annu Rev Public Health 1999 20 145 157 10.1146/annurev.publhealth.20.1.145 10352854 (Pubitemid 29242575)